z-logo
Premium
Efficacy of systemic minoxidil and tofacitinib combination in treatment‐resistant alopecia universalis
Author(s) -
Dincer Didem,
Tanacan Efsun,
Kose Ozkan Cansel
Publication year - 2021
Publication title -
journal of cosmetic dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.626
H-Index - 44
eISSN - 1473-2165
pISSN - 1473-2130
DOI - 10.1111/jocd.13812
Subject(s) - alopecia areata , minoxidil , alopecia universalis , hair loss , tofacitinib , medicine , dermatology , scalp , hair transplantation , hair follicle , rheumatoid arthritis
Alopecia areata (AA) is an autoimmune nonscarring alopecic disorder, which presents with varying amounts of hair loss, ranging from focal patchy loss to entire scalp and body hair loss. Treatment of AA is a challenging issue within dermatology practice. Although many treatment options are present, response to medications remains unsatisfactory, especially in severe and recalcitrant cases. In this study, we present a case of treatment‐resistant AU, which was successfully treated by the combination of tofacitinib and oral minoxidil.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here